Literature DB >> 12560158

High glucose potentiates mitogenic responses of cultured ovine coronary smooth muscle cells to platelet derived growth factor and transforming growth factor-beta1.

Peter J Little1, Terri J Allen, Kazuhiko Hashimura, Julie Nigro, Caroline A Farrelly, Rodney J Dilley.   

Abstract

Macrovascular complications in diabetes are associated with exaggerated growth responses of vascular smooth muscle cells. We studied the effect of high glucose media on the growth responses of vascular smooth muscle cells from the left anterior descending (LAD) coronary artery of young sheep. Experiments were conducted in DMEM containing 5.5 or 25 mmol/l glucose and mitogenic responses assessed by 3H-thymidine incorporation. In the absence of growth factors there was a slight and variable response to high glucose but the maximum response to platelet derived growth factor-bb (PDGF-bb) (100 ng/ml) was increased more than 2-fold. Transforming growth factor-beta1 (1 ng/ml) caused a 100% increase of the PDGF-bb response in both normal and high glucose media. The acute stimulatory effect of high glucose was not affected by pre-incubation of the cells for 24 h in the high glucose medium. The mitogenic response occurring in the presence of PDGF-bb and high glucose was totally inhibited by the tyrosine kinase inhibitors (imatinib and genistein) and could not be mimicked by increasing diacylglycerol in low glucose media with the diacylglycerol kinase inhibitor, R59949. In conclusion, high glucose, per se, only very weakly stimulates smooth muscle cell growth but it interacts positively to potentiate the responses to the vascular derived growth factors PDGF and TGF-beta1. The effect of high glucose is transduced via receptor tyrosine kinases and may not involve diacylglycerol that is subject to diacylglycerol kinase catabolism. The data provide explanations for the accelerated vascular smooth muscle cell proliferation in diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560158     DOI: 10.1016/s0168-8227(02)00201-2

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  4 in total

1.  Glucose consumption of vascular cell types in culture: toward optimization of experimental conditions.

Authors:  Keiichi Torimoto; Keisuke Okuno; Ryohei Kuroda; No'Ad Shanas; Stephanie M Cicalese; Kunie Eguchi; Katherine J Elliott; Tatsuo Kawai; Cali B Corbett; Amanda M Peluzzo; Amanda K St Paul; Michael V Autieri; Rosario Scalia; Victor Rizzo; Tomoki Hashimoto; Satoru Eguchi
Journal:  Am J Physiol Cell Physiol       Date:  2021-11-24       Impact factor: 5.282

2.  Anti-proliferative activity of oral anti-hyperglycemic agents on human vascular smooth muscle cells: thiazolidinediones (glitazones) have enhanced activity under high glucose conditions.

Authors:  Peter J Little; Narin Osman; Stephanie T de Dios; Nelly Cemerlang; Mandy Ballinger; Julie Nigro
Journal:  Cardiovasc Diabetol       Date:  2007-10-28       Impact factor: 9.951

Review 3.  Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis.

Authors:  Peter J Little; Mandy L Ballinger; Narin Osman
Journal:  Vasc Health Risk Manag       Date:  2007

Review 4.  TGFβ, smooth muscle cells and coronary artery disease: a review.

Authors:  Emma L Low; Andrew H Baker; Angela C Bradshaw
Journal:  Cell Signal       Date:  2018-09-15       Impact factor: 4.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.